Cardiff Oncology Inc
SWB:XE7C
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Cardiff Oncology Inc
SWB:XE7C
|
US |
|
P
|
Pilgrims Pride Corp
F:6PP
|
US |
|
E
|
Ecolab Inc
SWB:ECJ
|
US |
|
Li Ning Co Ltd
OTC:LNNGF
|
CN |
|
T
|
Thales SA
SWB:CSF
|
FR |
|
Stellantis NV
F:8TI
|
NL |
|
V
|
Vext Science Inc
CNSX:VEXT
|
CA |
|
M
|
Merck & Co Inc
XHAM:6MK
|
US |
|
U
|
UBS Group AG
BMV:UBSN
|
CH |
|
F
|
Ferrovial SA
XBER:UFG
|
ES |
|
Olema Pharmaceuticals Inc
NASDAQ:OLMA
|
US |
|
Lonza Group AG
OTC:LZAGY
|
CH |
|
A
|
Anheuser-Busch Inbev SA
BMV:ANB
|
BE |
|
D
|
Dominion Energy Inc
F:DOD
|
US |
|
T
|
TUI AG
F:TUI1
|
DE |
|
L
|
Lloyds Banking Group PLC
SWB:LLD
|
UK |
|
Fugro NV
OTC:FUGRF
|
NL |
|
F
|
Fastenal Co
XBER:FAS
|
US |
|
T
|
Teck Resources Ltd
XBER:TEKB
|
CA |
|
F
|
F5 Inc
XBER:FFV
|
US |
|
C
|
Conduent Inc
SWB:4C0
|
US |
|
Red Violet Inc
NASDAQ:RDVT
|
US |
|
S
|
Silgan Holdings Inc
F:SL3
|
US |
Bankruptcy Probability
Cardiff Oncology Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Cardiff Oncology Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Cardiff Oncology Inc
NASDAQ:CRDF
|
114.8m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
362.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
178.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
169.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
108.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
76.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
42.6B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
60.1B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Cardiff Oncology Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Cardiff Oncology Inc has no debt.
You can find a full breakdown on its Balance Sheet.
